Equities

Kidswell Bio Corp

4584:TYO

Kidswell Bio Corp

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)126.00
  • Today's Change-3.00 / -2.33%
  • Shares traded261.10k
  • 1 Year change-27.59%
  • Beta1.6854
Data delayed at least 20 minutes, as of Sep 20 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
OPERATIONS
Net income(1421)(656)(534)
Depreciation/depletion0.920.932.30
Non-Cash items86(378)(299)
Cash taxes paid, supplemental1.211.211.50
Cash interest paid, supplemental303816
Changes in working capital880(388)(339)
Total cash from operations(454)(1421)(1170)
INVESTING
Capital expenditures----(0.16)
Other investing and cash flow items, total--(29)527
Total cash from investing--(29)527
FINANCING
Financing cash flow items------
Total cash dividends paid------
Issuance (retirement) of stock, net99337369
Issuance (retirement) of debt, net6251,320--
Total cash from financing1,6181,356369
NET CHANGE IN CASH
Foreign exchange effects------
Net change in cash1,164(94)(274)
Net cash-begin balance/reserved for future use1,0671,1611,461
Net cash-end balance/reserved for future use2,2311,0671,187
SUPPLEMENTAL INCOME
Depreciation, supplemental0.920.932.30
Cash interest paid, supplemental303816
Cash taxes paid, supplemental1.211.211.50
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.